[144] STANDEX INTERNATIONAL CORP/DE/ SEC Filing

Rhea-AI Filing Summary

Standex International Corp. (SXI) notice reports a proposed sale of 11,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,365,000 and approximately 12,068,262 shares outstanding. The shares were acquired on 09/06/2023 by vesting of restricted stock units (RSU vest) from the issuer. The filing also discloses related sales within the past three months: a sale of 5,000 shares for $1,000,000 and a sale of 11,000 shares for $2,200,000, both dated 08/13/2025. The filer certifies no undisclosed material adverse information and references the Rule 10b5-1 trading plan representation.

Insights

Securities Analyst

TL;DR: Routine insider sale of vested RSUs via UBS totaling 11,000 shares; recent related sales also disclosed, appears procedural not transformative.

The filing shows a proposed sale of 11,000 common shares acquired by RSU vesting on 09/06/2023, executed through UBS Financial Services on the NYSE with an indicated aggregate market value of $2,365,000. The disclosure of prior sales on 08/13/2025 (5,000 shares for $1,000,000 and 11,000 shares for $2,200,000) documents recent dispositions that should be incorporated into any short-term insider activity review. Given the issuer's reported share count of 12,068,262, the proposed sale represents a small percentage of outstanding shares and is most consistent with routine liquidity events rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; includes RSU origin and attestation about material nonpublic information.

The form provides the necessary Rule 144 elements: acquisition date (09/06/2023), nature of acquisition (RSU vest), broker details (UBS Financial Services), and recent sales by related trusts. The signer represents no undisclosed material adverse information and indicates any reliance on a 10b5-1 plan would be noted. From a governance perspective this disclosure supports transparency around insider liquidity while documenting compliance statements required by securities rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	11000	2365000.00	12068262	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/06/2023	RSU Vest	Issuer			11000	09/06/2023	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
The David A. Dunbar Revocable Trust of 2015 23 KEEWAYDIN DRIVE SUITE 300 SALEM NH 03079	Common	08/13/2025	5000	1000000.00
The Joana H. Dunbar Irrevocable Trust of 2024 23 KEEWAYDIN DRIVE SUITE 300 SALEM NH 03079	Common	08/13/2025	11000	2200000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Standex International (SXI) disclose about the proposed sale?

The filing discloses a proposed sale of 11,000 common shares through UBS on the NYSE with an aggregate market value of $2,365,000.

How were the 11,000 shares acquired according to the filing?

The shares were acquired by RSU vesting on 09/06/2023, with the issuer listed as the source of the RSUs.

Are there any recent related sales disclosed in the Form 144?

Yes. The filing lists prior sales on 08/13/2025: 5,000 shares for $1,000,000 and 11,000 shares for $2,200,000 by related trusts.

Which broker and exchange are listed for the proposed sale?

The broker is UBS Financial Services, Inc. (Eleven Madison Avenue, New York) and the exchange is the NYSE.

Does the filing indicate compliance with Rule 10b5-1 or any attestation about material information?

The filer signs an attestation representing they do not know any material adverse information not publicly disclosed and references the option to indicate a Rule 10b5-1 plan adoption date if applicable.